EUVIMEDEUVIMED entdecken
Crossref

Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy

Naoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, Hiroki Usuku, Akihisa Tabira, Tetsuya Oguni, Masahiro Yamamoto, Kyoko Hirakawa, Masanobu Ishii, Noriaki Tabata, Tadashi Hoshiyama, Hisanori Kanazawa und 8 weitere

Circulation Journal · 25.03.2025 · 89 (4) · 421-431

DOI: 10.1253/circj.cj-24-0733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Journal, erschienen am 25.03.2025. Verfasst von Naoto Kuyama und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Benzoxazoles, Cardiomyopathies. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialBenzoxazolesCardiomyopathiesHumansMaleFemaleAgedTroponin TMiddle AgedNatriuretic Peptide, BrainPrognosisAged, 80 and overFollow-Up StudiesBiomarkersStroke VolumeVentricular Function, Left

Stichwörter der Autor:innen

Clinical prognosisHigh-sensitivity cardiac troponin TMultiparameter deteriorationTafamidis treatmentTransthyretin amyloid cardiomyopathy

Substanzen

tafamidisBenzoxazolesTroponin TNatriuretic Peptide, BrainBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.
  • Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University.
  • Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
  • Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.
  • Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kuyama, N., Izumiya, Y., Takashio, S., Usuku, H., Tabira, A., Oguni, T., Yamamoto, M., Hirakawa, K., Ishii, M., Tabata, N., Hoshiyama, T., Kanazawa, H., Hanatani, S., Kidoh, M., Oda, S., Matsuzawa, Y., Yamamoto, E., Hirai, T., Ueda, M., & Tsujita, K. (2025). Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy. Circulation Journal, 89(4), 421-431. https://doi.org/10.1253/circj.cj-24-0733

Vancouver

Kuyama N, Izumiya Y, Takashio S, Usuku H, Tabira A, Oguni T, et al. Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy. Circulation Journal. 2025;89(4):421-431. doi:10.1253/circj.cj-24-0733

BibTeX
@article{Kuyama2025,
  author = {Kuyama, Naoto and Izumiya, Yasuhiro and Takashio, Seiji and Usuku, Hiroki and Tabira, Akihisa and Oguni, Tetsuya and Yamamoto, Masahiro and Hirakawa, Kyoko and Ishii, Masanobu and Tabata, Noriaki and Hoshiyama, Tadashi and Kanazawa, Hisanori and Hanatani, Shinsuke and Kidoh, Masafumi and Oda, Seitaro and Matsuzawa, Yasushi and Yamamoto, Eiichiro and Hirai, Toshinori and Ueda, Mitsuharu and Tsujita, Kenichi},
  title = {Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy},
  journal = {Circulation Journal},
  year = {2025},
  volume = {89},
  number = {4},
  pages = {421--431},
  doi = {10.1253/circj.cj-24-0733}
}
Kostenlos starten →